Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Thursday announced second-quarter 2024 financial results, reporting a decline in adjusted earnings and an increase
AbbVie Inc.
-(ABBV)
XNYS:ABBV
Highlights of AbbVie’s Q1 2024 financial results
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest
ABBV Earnings: Everything you need to know about AbbVie’s Q4 report
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced fourth-quarter 2023 financial results, reporting lower revenues and net income. The company reported
ABBV Earnings: A snapshot of AbbVie’s Q3 2023 report
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced third-quarter 2023 financial results, reporting lower revenues and net income. The company reported
AbbVie (ABBV) Q2 2023 Earnings: Key financials and quarterly highlights
AbbVie (NYSE: ABBV) reported second quarter 2023 earnings results today. Worldwide net revenues were $13.8 billion, down 4.9% on a reported basis,
ABBV Infographic: AbbVie’s Q1 2023 earnings and revenue decline
Pharmaceutical company AbbVie, Inc. (NYSE: ABBV) reported a decrease in first-quarter 2023 adjusted earnings and revenues. The company also provided guidance for
AbbVie (ABBV) Q1 2023 Earnings Call Transcript
AbbVie (NYSE: ABBV) Q1 2023 Earnings Call dated Apr. 27, 2023 Corporate Participants: Elizabeth Shea -- Senior Vice President of Investor Relations
AbbVie sees near-term slowdown; looks prepared to tackle patent expiration
AbbVie, Inc. (NYSE: ABBV) has delivered yet another quarter of strong top-line and earnings performance but issued cautious guidance for fiscal 2023
AbbVie (ABBV) Q4 2022 Earnings Call Transcript
AbbVie (NYSE: ABBV) Q4 2022 earnings call dated Feb. 09, 2023 Corporate Participants: Elizabeth Shea -- Vice President, Investor Relations Richard A. Gonzalez -- Chairman of
AbbVie (ABBV) Q4 2022 Earnings: Key financials and quarterly highlights
AbbVie (NYSE: ABBV) reported fourth quarter 2022 earnings results today. Worldwide net revenues increased 1.6% year-over-year to $15.1 billion. Net earnings attributable
ABBV Infographic: AbbVie’s Q3 earnings beat estimates; revenue up 3%
Pharmaceutical company AbbVie, Inc. (NYSE: ABBV) reported a sharp increase in third-quarter adjusted earnings. The bottom line topped expectations, while revenues missed.
AbbVie (ABBV) Q2 2022 Earnings Call Transcript
AbbVie (NYSE: ABBV) Q2 2022 earnings call dated Jul. 29, 2022 Corporate Participants: Elizabeth Shea -- Vice President, Head of Investor Relations Richard Gonzalez -- Chairman
ABBV Earnings: Highlights of AbbVie’s Q2 2022 financial results
Pharmaceutical company AbbVie, Inc. (NYSE: ABBV) has reported double-digit growth in second-quarter adjusted earnings, reflecting an increase in revenues. The company also
Despite generic threat, AbbVie (ABBV) remains a good long-term bet
Biopharmaceutical firm AbbVie Inc. (NYSE: ABBV) is currently at a crucial juncture as it strives to overcome the threat from generic competitors
AbbVie (ABBV) Q1 2022 Earnings Call Transcript
AbbVie (NYSE: ABBV) Q1 2022 earnings call dated Apr. 29, 2022 Corporate Participants: Elizabeth Shea -- Vice President, Head of Investor Relations Richard A.
AbbVie (ABBV) Q4 2021 Earnings Call Transcript
AbbVie (NYSE: ABBV) Q4 2021 earnings call dated Feb. 02, 2022 Corporate Participants: Elizabeth Shea -- Vice President, Investor Relations Richard A. Gonzalez -- Chairman of
AbbVie (ABBV) Earnings: Key financials and quarterly highlights
AbbVie (NYSE: ABBV) today reported its fourth-quarter financial results for the period ended December 31, 2021. Net revenues increased 7.4% to $14.8
AbbVie (ABBV) stock research summary | Q3 2021
The AlphaStreet research report provides actionable data and insights into AbbVie’s fundamentals, the industry, and competition. The report is meant as a
Earnings: AbbVie (ABBV) Q3 profit rises, beats estimates on higher revenues
Biopharmaceutical company AbbVie Inc. (NYSE: ABBV) on Friday said its third-quarter revenues and net profit increased from last year. The results also
AbbVie Inc (ABBV) Q2 2021 Earnings Call Transcript
AbbVie Inc (NYSE: ABBV) Q2 2021 earnings call dated July 30, 2021 Corporate Participants: Liz Shea -- Vice President of Investor Relations Richard A.
AbbVie (ABBV) Earnings: Key financials and quarterly highlights
AbbVie (NYSE: ABBV) today reported its second-quarter financial results for the period ended June 30, 2021. Net revenues increased 34% to $13.9